Hubei Biocause Heilen Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate
Hubei Biocause Heilen Pharmaceutical Co. Ltd. cash flow reinvestment rate. Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) has a Cash Flow Reinvestment Rate of 1.44x as of September 2025, reinvesting CN¥16.64 Million (capex CN¥16.64 Million ) from operating cash flow of CN¥11.57 Million. See Hubei Biocause Heilen Pharmaceutical Co. (301211) flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hubei Biocause Heilen Pharmaceutical Co. Ltd. (2018–2025)
Cash flow reinvestment rate of Hubei Biocause Heilen Pharmaceutical Co. Ltd. from 2018 to 2025. Historical reinvestment intensity for Hubei Biocause Heilen Pharmaceutical Co. Ltd. across 8 annual periods. Explore how well can Hubei Biocause Heilen Pharmaceutical Co. service its debt to assess how comfortably operating cash covers total debt obligations.
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate by Year (2018–2025)
Hubei Biocause Heilen Pharmaceutical Co. Ltd. cash flow reinvestment rate by year from 2018 to 2025. Year-by-year capital reinvestment analysis for Hubei Biocause Heilen Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see Hubei Biocause Heilen Pharmaceutical Co. cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.92x | CN¥67.34 Million | CN¥7.55 Million | CN¥52.33 Million | ▼ -22.8% |
| 2024 | 11.55x | CN¥1.11 Billion | CN¥96.07 Million | CN¥164.43 Million | ▲ +661.3% |
| 2023 | 1.52x | CN¥207.94 Million | CN¥137.06 Million | CN¥186.53 Million | ▲ +48.7% |
| 2022 | 1.02x | CN¥255.82 Million | CN¥250.79 Million | CN¥75.95 Million | ▼ -49.6% |
| 2021 | 2.02x | CN¥250.71 Million | CN¥123.98 Million | CN¥21.07 Million | ▲ +326.1% |
| 2020 | 0.47x | CN¥57.74 Million | CN¥121.67 Million | CN¥13.39 Million | ▼ -38.7% |
| 2019 | 0.77x | CN¥288.37 Million | CN¥372.33 Million | CN¥32.34 Million | ▲ +135.3% |
| 2018 | 0.33x | CN¥25.08 Million | CN¥76.18 Million | CN¥25.08 Million | — |